2Zhang W, Doherty M, Bardin T, et al. EULAR evidence based recommendations for gout. Part Ⅱ : Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, 2006,65 : 1312-1324.
3Bruce SP. Febuxostat : a selective xanthine oxidase inhibitor for the treatment of hyperuricemia and gout. Ann Pharmacother,2006,40 : 2187-2194.
4Richette P, Briere C, Hoenen-Clavert V, et al. Rasburicase for tophaceous gout not treatable with allopurinol: an exploratory study. J Rheumatol,2007 ,34 :2093-2098.
5Stamp L, Searle M, O'Donnell J, et al. Gout in solid organ transplantation: a challenging clinical problem. Drugs,2005,65: 2593 -2611.
6Fam AG, Dunne SM, Iazzetta J, et ah Efficacy and safety of desensitization to allopurinol following cutaneous reactions. Arthritis Rheum ,2001,44:231-238.
7Pohar S, Murphy G. Febuxostat for prevention of gout attacks. Issues Emerg Health Technol, 2006, ( 87 ) : 1-4.
8Stamp LK, O'Donnell JL, Chapman PT. Emerging therapies in the long-term management of hyperuricaemia and gout. Intern Med J, 2007,37:258-266.
9De Angelis S, Noee A, Di Renzo L, et al. Is rasburicase an effective ahernative to allopurinol for management of hyperuriccmia in renal failure patients? A double blind-randomized study. Eur Rev Med Pharmacol Sci,2007,11 : 179-184.
10Naritomi H, Fujita T, Ito S,et al. Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin Ⅱ Antagonist Losartan Therapy (J-HEALTH) study. Hypertens Res,2008,31 : 295-304.
5Wallace SL,Robinson H,Masi AT,et al.Preliminary criteria for the classification of the acute arthritis of primary gouty.In:Klippel JH,editors.Primer on the Rheumatic Diseases.Atlanta:Arthritis Foundation,2001.637.
6Finger DR.Hypouricemic agents and colchicine.In:West SG,editors.Rheumatology Secrets,Philadelphia:Hanley & Belfus,1997.490-495.
7Wallace SL,Singer J.Therapy in gout.Rheum Dis Clin Nor Ame,1988,14:441-457.
8Becker MA,Schumacher HR,Wortmann RL,et al.Febuxostat compared with allopurinol in patients with hyperuricemia and gout.New Engl J Med,2005,353:2450-2461.
9Feher MD,Hepburn AL,Hogarth MB,et al.Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout.Rheumatology,2003,42:321-325.
10Fiehn C,Meier M,Grenacher L,et al.Successful treatment of chronic tophaceous gout with infliximab (Remicade).Ann Rheum Dis,2004,63(Suppl Ⅰ):378.
